ESTUTC-5 New YorkLog in Sign up

CBIO
Crescent Biopharma, Inc. Common Stock
stockNASDAQ

Market OpenNov 10, 2026 1:59:43 PM EST

13.62USD-0.183%(-0.03)77,649

11.69Bid13.87Ask2.18Spread

CBIO News

Day breaks

04:15 PM ESTCrescent Biopharma Announces Grants of Inducement Awards ·

GlobeNewswire Inc.

05:38 AM ESTBlackRock, Inc. Adds 803,529 Shares of Crescent Biopharma Inc (CBIO) in Q3 2026 Filing ·

GuruFocus

07:30 AM ESTCrescent Biopharma to Present at November Investor Conferences ·

GlobeNewswire Inc.

08:56 AM EDTH.C. Wainwright reiterates Crescent Biopharma stock rating at buy ·

Investing.com

04:20 PM EDTCrescent Biopharma advances cancer drug trials across portfolio ·

Investing.com

04:15 PM EDTCrescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC Combination Studies with CR-001 ·

GlobeNewswire Inc.

04:15 PM EDTCrescent Biopharma Announces Grants of Inducement Awards ·

GlobeNewswire Inc.

08:39 AM EDTStifel reiterates Buy on Crescent Biopharma stock, $28 target ·

Investing.com

08:14 AM EDTCrescent Biopharma stock rating upgraded to buy at H.C. Wainwright ·

Investing.com

07:30 AM EDTCrescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors ·

GlobeNewswire Inc.

04:15 PM EDTCrescent Biopharma Announces Grants of Inducement Awards ·

GlobeNewswire Inc.

05:11 AM EDTCrescent Biopharma, Inc. (CBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha